Douglas Ingram

CEO and President at Sarepta Therapeutics, Inc. - Cambridge, MA, US

Douglas Ingram's Colleagues at Sarepta Therapeutics, Inc.
David Miller

Executive Director, Head of RWE

Contact David Miller

Jon White

senior director, head of underwriting specialist sales

Contact Jon White

Jianbo Zhang

principal scientist, bioanalytics

Contact Jianbo Zhang

Liz Smyth

US Head of Medical Affairs - Interim

Contact Liz Smyth

Valarie Richman

Executive Assistant To Chief Executive Officer

Contact Valarie Richman

View All Douglas Ingram's Colleagues
Douglas Ingram's Contact Details
HQ
888-727-3782
Location
Company
Sarepta Therapeutics, Inc.
Douglas Ingram's Company Details

Sarepta Therapeutics, Inc.

Cambridge, MA, US • 1000 - 4999 Employees
BioTech/Drugs

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.

Biotechnology Healthcare Pharmaceuticals Biotech BioTech/Drugs Commercial Physical Research
Details about Sarepta Therapeutics, Inc.
Frequently Asked Questions about Douglas Ingram
Douglas Ingram currently works for Sarepta Therapeutics.
Douglas Ingram's role at Sarepta Therapeutics is CEO and President.
Douglas Ingram's email address is ***@sarepta.com. To view Douglas Ingram's full email address, please signup to ConnectPlex.
Douglas Ingram works in the Biotechnology industry.
Douglas Ingram's colleagues at Sarepta Therapeutics, Inc. are Jameel Khan, David Miller, Jon White, Jianbo Zhang, Liz Smyth, Chris Brown, Valarie Richman and others.
Douglas Ingram's phone number is ["+17142464535"]
See more information about Douglas Ingram